AELIUS BIOTECH LIMITED
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10- Legal registered address
- Blandford Studios 12 Blandford Square Newcastle Upon Tyne United Kingdom NE1 4HZ Copied!
Latest financial results as of 31 August 2025- Current assets
- £927.32k
- Fixed assets
- £372.17k
- Current creditors
- £322.04k
- Shareholders funds
- £974.97k
View full financial accounts- Current assets
- £927.32k
- Fixed assets
- £372.17k
- Current creditors
- £322.04k
- Shareholders funds
- £974.97k
- Company number
- 11535653 Copied!
Accounts
Latest annual accounts were to 31 December 2024
Next annual accounts are due by 30 September 2026
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 1 June 2025
Next statement due by 15 June 2026
Nature of business (SIC)
72190 - Other research and experimental development on natural sciences and engineering
86900 - Other human health activities
Latest company documents
| Date | Description |
|---|---|
| 25/07/2525 July 2025 New | Micro company accounts made up to 2024-12-31 |
| 02/06/252 June 2025 | Confirmation statement made on 2025-06-01 with no updates |
| 01/05/251 May 2025 | Registered office address changed from The Grainger Suite Dobson House, Regent Centre Gosforth Newcastle upon Tyne NE3 3PF England to Blandford Studios 12 Blandford Square Newcastle upon Tyne NE1 4HZ on 2025-05-01 |
| 13/03/2513 March 2025 | Termination of appointment of Geoffrey Charles Peter Maclauchlan as a secretary on 2025-03-13 |
| 13/03/2513 March 2025 | Termination of appointment of Geoffrey Charles Peter Maclauchlan as a director on 2025-03-13 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company